Behavioural and biochemical studies of citalopram and WAY 100635 in rat chronic mild stress model

Pharmacology, Biochemistry, and Behavior
M PappC Sánchez

Abstract

Reversal of chronic mild stress (CMS)-induced decrease of sucrose consumption has been studied in rats after 2, 7, 14, and 35 days treatment with imipramine, citalopram (both 10 mg/kg per day, i.p.), WAY 100635 (0.2 mg/kg sc, b.i.d.), and citalopram plus WAY 100635. Bmax, Kd, and functional status [cyclic AMP (cAMP) generation] of beta1-adrenoceptors were assessed in cortical tissue at the same time points. Citalopram reversed CMS-induced reduction of sucrose intake at an earlier time point than imipramine. WAY 100635 was not effective and did not potentiate the effect of citalopram. CMS produced increase of Bmax. Imipramine decreased Bmax in controls (Days 2, 7, 14, and 35) and normalised Bmax in stressed animals (Day 35). Citalopram, WAY 100635, and the combination increased Bmax in stressed animals and controls (Days 14 and 35). Inconsistent changes of Kd values and of cAMP responses to noradrenaline (NA) stimulation were observed. Thus stress- and drug-induced effects on beta1-adrenoceptors do not appear to be a common biochemical marker of antidepressant-like activity in the CMS model.

References

Aug 1, 1990·Biological Psychiatry·R MuscatP Willner
Apr 1, 1974·Analytical Biochemistry·Y SalomonM Rodbell
Jul 1, 1994·Trends in Pharmacological Sciences·P Blier, C de Montigny
Jun 1, 1994·Psychiatry Research·F PettyS Jordan
Jul 8, 1996·Journal of Affective Disorders·M Van AmeringenC Wilson
Oct 1, 1996·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·L RomeroP Blier
May 1, 1997·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·P BlierC de Montigny
Jul 26, 1997·Lancet·M T Isaac, M B Tome
Apr 16, 1998·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·A Newman-TancrediM J Millan
Oct 16, 1999·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·M Isaac

❮ Previous
Next ❯

Citations

Mar 23, 2004·European Journal of Pharmacology·Ewa TatarczyńskaEwa Chojnacka-Wójcik
Feb 20, 2010·Behavioural Pharmacology·Mónica Romano-Torres, Alonso Fernández-Guasti
Nov 8, 2008·Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine·Yuan-yuan GongXing-wei Wu
May 30, 2009·Physiology & Behavior·E F KamperZ Papadopoulou-Daifoti
Feb 1, 2008·European Journal of Pharmacology·Anna Wesołowska, Agnieszka Nikiforuk
May 21, 2005·Behavioural Brain Research·Stathis BekrisZeta Papadopoulou-Daifoti
Mar 10, 2015·Neuropharmacology·Sean D GeddesJean-Claude Béïque
Jul 11, 2012·Neuroscience and Biobehavioral Reviews·Matthew N HillJoanne Weinberg
Nov 18, 2005·Behavioural Brain Research·Hang ZhengF Halberg
Jun 5, 2004·European Journal of Pharmacology·David H OverstreetSandra Hogg
Nov 23, 2007·Physiology & Behavior·C DallaZ Papadopoulou-Daifoti
Jun 20, 2008·Journal of Psychopharmacology·S H WangB A Chen
Jun 1, 2008·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Sang-Ha ParkKyung-Ho Shin
Apr 17, 2019·The Journal of Clinical Investigation·Taro KatoRonald S Duman
Jul 28, 2011·Stress : the International Journal on the Biology of Stress·Yong ChenPing Zhang
Jul 17, 2014·Behavioural Pharmacology·Miao-Kun Sun, Daniel L Alkon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.